US Stock MarketDetailed Quotes

AVNS Avanos Medical

Watchlist
  • 16.080
  • -0.460-2.78%
Close Dec 20 16:00 ET
  • 16.080
  • 0.0000.00%
Post 16:15 ET
738.99MMarket Cap47.29P/E (TTM)

Avanos Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-20.96%23M
1,169.23%27.8M
-17.65%-8M
-64.36%32.4M
-62.31%12.7M
2.46%29.1M
-109.63%-2.6M
-477.78%-6.8M
4.12%90.9M
-35.32%33.7M
Net income from continuing operations
216.22%4.3M
102.64%1.8M
-80.00%-900K
-222.38%-61.8M
-37.87%10.5M
-123.57%-3.7M
-644.80%-68.1M
-109.26%-500K
701.59%50.5M
46.96%16.9M
Operating gains losses
--100K
--0
--300K
6,509.09%72.7M
--71.6M
----
----
----
-86.25%1.1M
----
Depreciation and amortization
6.36%11.7M
-1.74%11.3M
-5.79%11.4M
-3.35%46.1M
-14.18%11.5M
-5.17%11M
-0.86%11.5M
9.01%12.1M
24.54%47.7M
41.05%13.4M
Change In working capital
-82.04%3.7M
161.94%8.3M
-13.99%-22M
25.93%-18M
-268.75%-5.9M
705.88%20.6M
-1,016.67%-13.4M
-6.63%-19.3M
-199.18%-24.3M
-112.60%-1.6M
-Change in receivables
-169.37%-7.7M
-1.37%-7.4M
-68.70%8.2M
257.89%39M
148.13%9M
1,133.33%11.1M
-182.95%-7.3M
266.88%26.2M
-128.70%-24.7M
61.04%-18.7M
-Change in inventory
-70.77%1.9M
31.11%-3.1M
45.35%-4.7M
115.21%4.7M
130.61%11.3M
136.52%6.5M
68.09%-4.5M
-120.51%-8.6M
-296.82%-30.9M
-15.52%4.9M
-Change in prepaid assets
1,950.00%3.7M
121.05%4.2M
86.67%-200K
-753.33%-19.6M
-3,860.00%-19.8M
-106.90%-200K
280.00%1.9M
-1,600.00%-1.5M
257.89%3M
83.33%-500K
-Change in payables and accrued expense
81.25%5.8M
517.14%14.6M
28.53%-25.3M
-248.76%-42.1M
-150.39%-6.4M
-69.81%3.2M
-197.22%-3.5M
-2,628.57%-35.4M
31.63%28.3M
-78.07%12.7M
Cash from discontinued investing activities
Operating cash flow
-20.96%23M
1,169.23%27.8M
-17.65%-8M
-64.36%32.4M
-62.31%12.7M
2.46%29.1M
-109.63%-2.6M
-477.78%-6.8M
4.12%90.9M
-35.32%33.7M
Investing cash flow
Cash flow from continuing investing activities
75.46%-12M
9.23%-5.9M
50.00%-2M
115.95%21.6M
1,753.06%81M
-940.43%-48.9M
-58.54%-6.5M
96.71%-4M
-544.76%-135.4M
-4.26%-4.9M
Capital expenditure reported
23.08%-3M
-47.50%-5.9M
-2.50%-4.1M
7.77%-17.8M
-20.41%-5.9M
26.42%-3.9M
2.44%-4M
20.00%-4M
8.10%-19.3M
-4.26%-4.9M
Net business purchase and sale
--0
--0
--2.1M
133.94%39.4M
--39.4M
--0
--0
--0
---116.1M
----
Net other investing changes
----
----
----
----
----
-7,600.00%-45M
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
75.46%-12M
9.23%-5.9M
50.00%-2M
115.95%21.6M
1,753.06%81M
-940.43%-48.9M
-58.54%-6.5M
96.71%-4M
-544.76%-135.4M
-4.26%-4.9M
Financing cash flow
Cash flow from continuing financing activities
-134.26%-16M
-21.95%-5M
96.83%-700K
-266.14%-94.2M
-423.74%-114.7M
557.84%46.7M
75.74%-4.1M
-120.91%-22.1M
202.53%56.7M
15.12%-21.9M
Net issuance payments of debt
-124.00%-13.2M
0.00%-1.5M
138.89%8.4M
-162.57%-64.7M
-347.22%-96.6M
--55M
---1.5M
-117.28%-21.6M
306.80%103.4M
-44.00%-21.6M
Net common stock issuance
98.91%-100K
-34.62%-3.5M
-727.27%-9.1M
58.02%-19.1M
-1,450.00%-6.2M
16.36%-9.2M
82.31%-2.6M
94.33%-1.1M
-295.65%-45.5M
96.33%-400K
Proceeds from stock option exercised by employees
-33.33%600K
--0
-16.67%500K
-23.53%1.3M
-300.00%-200K
12.50%900K
--0
-14.29%600K
-72.58%1.7M
0.00%100K
Net other financing activities
---3.3M
--0
---500K
-303.45%-11.7M
----
----
----
----
---2.9M
--0
Cash from discontinued financing activities
Financing cash flow
-134.26%-16M
-21.95%-5M
96.83%-700K
-266.14%-94.2M
-423.74%-114.7M
557.84%46.7M
75.74%-4.1M
-120.91%-22.1M
202.53%56.7M
15.12%-21.9M
Net cash flow
Beginning cash position
12.71%92.2M
-20.79%75.8M
-31.32%87.7M
7.76%127.7M
-8.46%107.1M
-23.19%81.8M
-8.25%95.7M
7.76%127.7M
6.28%118.5M
19.63%117M
Current changes in cash
-118.59%-5M
228.03%16.9M
67.48%-10.7M
-429.51%-40.2M
-404.35%-21M
99.26%26.9M
-320.00%-13.2M
-131.69%-32.9M
10.91%12.2M
-68.06%6.9M
Effect of exchange rate changes
212.50%1.8M
28.57%-500K
-233.33%-1.2M
106.67%200K
-57.89%1.6M
46.67%-1.6M
81.58%-700K
--900K
25.00%-3M
522.22%3.8M
End cash Position
-16.90%89M
12.71%92.2M
-20.79%75.8M
-31.32%87.7M
-31.32%87.7M
-8.46%107.1M
-23.19%81.8M
-8.25%95.7M
7.76%127.7M
7.76%127.7M
Free cash flow
-20.63%20M
431.82%21.9M
-12.04%-12.1M
-79.61%14.6M
-76.39%6.8M
9.09%25.2M
-128.82%-6.6M
-237.50%-10.8M
7.99%71.6M
-39.24%28.8M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -20.96%23M1,169.23%27.8M-17.65%-8M-64.36%32.4M-62.31%12.7M2.46%29.1M-109.63%-2.6M-477.78%-6.8M4.12%90.9M-35.32%33.7M
Net income from continuing operations 216.22%4.3M102.64%1.8M-80.00%-900K-222.38%-61.8M-37.87%10.5M-123.57%-3.7M-644.80%-68.1M-109.26%-500K701.59%50.5M46.96%16.9M
Operating gains losses --100K--0--300K6,509.09%72.7M--71.6M-------------86.25%1.1M----
Depreciation and amortization 6.36%11.7M-1.74%11.3M-5.79%11.4M-3.35%46.1M-14.18%11.5M-5.17%11M-0.86%11.5M9.01%12.1M24.54%47.7M41.05%13.4M
Change In working capital -82.04%3.7M161.94%8.3M-13.99%-22M25.93%-18M-268.75%-5.9M705.88%20.6M-1,016.67%-13.4M-6.63%-19.3M-199.18%-24.3M-112.60%-1.6M
-Change in receivables -169.37%-7.7M-1.37%-7.4M-68.70%8.2M257.89%39M148.13%9M1,133.33%11.1M-182.95%-7.3M266.88%26.2M-128.70%-24.7M61.04%-18.7M
-Change in inventory -70.77%1.9M31.11%-3.1M45.35%-4.7M115.21%4.7M130.61%11.3M136.52%6.5M68.09%-4.5M-120.51%-8.6M-296.82%-30.9M-15.52%4.9M
-Change in prepaid assets 1,950.00%3.7M121.05%4.2M86.67%-200K-753.33%-19.6M-3,860.00%-19.8M-106.90%-200K280.00%1.9M-1,600.00%-1.5M257.89%3M83.33%-500K
-Change in payables and accrued expense 81.25%5.8M517.14%14.6M28.53%-25.3M-248.76%-42.1M-150.39%-6.4M-69.81%3.2M-197.22%-3.5M-2,628.57%-35.4M31.63%28.3M-78.07%12.7M
Cash from discontinued investing activities
Operating cash flow -20.96%23M1,169.23%27.8M-17.65%-8M-64.36%32.4M-62.31%12.7M2.46%29.1M-109.63%-2.6M-477.78%-6.8M4.12%90.9M-35.32%33.7M
Investing cash flow
Cash flow from continuing investing activities 75.46%-12M9.23%-5.9M50.00%-2M115.95%21.6M1,753.06%81M-940.43%-48.9M-58.54%-6.5M96.71%-4M-544.76%-135.4M-4.26%-4.9M
Capital expenditure reported 23.08%-3M-47.50%-5.9M-2.50%-4.1M7.77%-17.8M-20.41%-5.9M26.42%-3.9M2.44%-4M20.00%-4M8.10%-19.3M-4.26%-4.9M
Net business purchase and sale --0--0--2.1M133.94%39.4M--39.4M--0--0--0---116.1M----
Net other investing changes ---------------------7,600.00%-45M----------------
Cash from discontinued investing activities
Investing cash flow 75.46%-12M9.23%-5.9M50.00%-2M115.95%21.6M1,753.06%81M-940.43%-48.9M-58.54%-6.5M96.71%-4M-544.76%-135.4M-4.26%-4.9M
Financing cash flow
Cash flow from continuing financing activities -134.26%-16M-21.95%-5M96.83%-700K-266.14%-94.2M-423.74%-114.7M557.84%46.7M75.74%-4.1M-120.91%-22.1M202.53%56.7M15.12%-21.9M
Net issuance payments of debt -124.00%-13.2M0.00%-1.5M138.89%8.4M-162.57%-64.7M-347.22%-96.6M--55M---1.5M-117.28%-21.6M306.80%103.4M-44.00%-21.6M
Net common stock issuance 98.91%-100K-34.62%-3.5M-727.27%-9.1M58.02%-19.1M-1,450.00%-6.2M16.36%-9.2M82.31%-2.6M94.33%-1.1M-295.65%-45.5M96.33%-400K
Proceeds from stock option exercised by employees -33.33%600K--0-16.67%500K-23.53%1.3M-300.00%-200K12.50%900K--0-14.29%600K-72.58%1.7M0.00%100K
Net other financing activities ---3.3M--0---500K-303.45%-11.7M-------------------2.9M--0
Cash from discontinued financing activities
Financing cash flow -134.26%-16M-21.95%-5M96.83%-700K-266.14%-94.2M-423.74%-114.7M557.84%46.7M75.74%-4.1M-120.91%-22.1M202.53%56.7M15.12%-21.9M
Net cash flow
Beginning cash position 12.71%92.2M-20.79%75.8M-31.32%87.7M7.76%127.7M-8.46%107.1M-23.19%81.8M-8.25%95.7M7.76%127.7M6.28%118.5M19.63%117M
Current changes in cash -118.59%-5M228.03%16.9M67.48%-10.7M-429.51%-40.2M-404.35%-21M99.26%26.9M-320.00%-13.2M-131.69%-32.9M10.91%12.2M-68.06%6.9M
Effect of exchange rate changes 212.50%1.8M28.57%-500K-233.33%-1.2M106.67%200K-57.89%1.6M46.67%-1.6M81.58%-700K--900K25.00%-3M522.22%3.8M
End cash Position -16.90%89M12.71%92.2M-20.79%75.8M-31.32%87.7M-31.32%87.7M-8.46%107.1M-23.19%81.8M-8.25%95.7M7.76%127.7M7.76%127.7M
Free cash flow -20.63%20M431.82%21.9M-12.04%-12.1M-79.61%14.6M-76.39%6.8M9.09%25.2M-128.82%-6.6M-237.50%-10.8M7.99%71.6M-39.24%28.8M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.